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Overcoming specific fears and subsequent anxiety can be greatly enhanced by the presence of familiar social partners, but the neural
circuitry that controls this phenomenon remains unclear. To overcome this, the social interaction (SI) habituation test was developed in
this lab to systematically investigate the effects of social familiarity on anxiety-like behavior in rats. Here, we show that social familiarity
selectively reduced anxiety-like behaviors induced by an ethological anxiogenic stimulus. The anxiolytic effect of social familiarity could be
elicited over multiple training sessions and was specific to both the presence of the anxiogenic stimulus and the familiar social partner. In
addition, socially familiar conspecifics served as a safety signal, as anxiety-like responses returned in the absence of the familiar partner.
The expression of the social familiarity-induced anxiolysis (SFiA) appears dependent on the prefrontal cortex (PFC), an area associated
with cortical regulation of fear and anxiety behaviors. Inhibition of the PFC, with bilateral injections of the GABAA agonist muscimol,
selectively blocked the expression of SFiA while having no effect on SI with a novel partner. Finally, the effect of D-cycloserine, a cognitive
enhancer that clinically enhances behavioral treatments for anxiety, was investigated with SFiA. D-cycloserine, when paired with familiarity
training sessions, selectively enhanced the rate at which SFiA was acquired. Collectively, these outcomes suggest that the PFC has a
pivotal role in SFiA, a complex behavior involving the integration of social cues of familiarity with contextual and emotional information to
regulate anxiety-like behavior.
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To ensure individual and species survival, complex social
behaviors have developed over time (Amodio and Frith,
2006; Cohen, 2004; Strodl and Schausberger, 2012), and in
multiple mammalian species, the presence of a conspecific
reduces behavioral and autonomic responses to a threat
(Davitz and Mason, 1955; DeVries et al, 2003; Hennessy
et al, 2000; Hennessy et al, 2002; Kiyokawa et al, 2007, 2009,
2012; Nakayasu and Kato, 2011; Terranova et al, 1999). Such
reductions in threat responses can be even greater when the
conspecific is familiar. In addition, perception of pain and
emotional distress to the threat of a painful stimulus is
reduced when the subject is in contact with or viewing a
picture of a familiar person compared with an unfamiliar
person (Coan et al, 2006; Eisenberger et al, 2011). This effect
of social familiarity is also at the core of many behavioral
and cognitive therapies for anxiety where the subject’s
perceived alliance with the therapist is integral to the
success of the treatment (Martin et al, 2000). Although
alleviation of anxiety through social familiarity is widely
accepted, very few studies have systematically investigated
this effect, and thus little is known about the mechanisms
and neural circuits that regulate it.
Preclinical modeling of social familiarity-induced inhibi-
tion of fear and/or anxiety is difficult, as many validated
preclinical tests such as fear conditioning, elevated plus
maze, or open field are confounded by the addition of a
conspecific. However, the presence of a conspecific is at the
core of the social interaction (SI) test (File and Hyde, 1978).
Previously, we developed a modified version of the SI test,
termed as the social interaction–habituation test (SI-hab),
which permits using the same conspecific partner repeat-
edly to investigate the regulation of anxiety-like behavior,
by social familiarity (Truitt et al, 2007). Social familiarity, as
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investigated by SI-hab in rats, reduces chronic anxiety-like
behavior induced by pharmacological activation of the
basolateral amygdala (BLA) (Truitt et al, 2007). In addition,
this ability of social familiarity to inhibit anxiety-like
behavior was dependent on a subpopulation of inhibitory
BLA interneurons that may be activated by inputs from the
medial prefrontal cortex (mPFC).
The mPFC has been implicated in the regulation of both
social behavior (Adolphs, 2010; Fossati, 2012; Meyer-
Lindenberg and Tost, 2012) and top-down regulation of
anxiety (Hartley and Phelps, 2010; Kim et al, 2011b),
making it a likely neural substrate for regulating social
familiarity-induced reductions in anxiety. Damage within
the mPFC is linked specifically to social deficits occurring
after traumatic brain injury (Spikman et al, 2012) and sub-
structures within the mPFC, including the infralimbic
cortex (IL) of the rat, have recently been demonstrated to
be critical for expression of key social behaviors during
development (van Kerkhof et al, 2013a, 2013b). The IL and
the similar human structure, the subgenual ventral mPFC
(vmPFC), are well known sites for cortically driven
reductions in anxiety through safety learning. The IL/
vmPFC is also activated in response to stimuli that signal
safety (Gupta et al, 2013; Herry and Mons, 2004; Knapska
and Maren, 2009; Phelps et al, 2004; Schiller et al, 2008).
Activating the IL enhances and emulates extinction of fear
conditioning (Milad and Quirk, 2002; Thompson et al,
2010), likely via connections with the amygdala (Knapska
et al, 2012).
The vmPFC and its connectivity to the amygdala are also
tightly linked to emotion regulation including anxiety, and
the strength of this connection can predict positive outcome
for cognitive behavioral therapies (Bishop et al, 2004; Kim
et al, 2011a, 2011b; Pezawas et al, 2005). Cognitive
behavioral therapies, such as exposure therapy, are a form
of safety learning that can be enhanced (reduction in the
number of pairings) in numerous animal and human
studies by D-cycloserine, an allosteric NMDA receptor
partial agonist (Davis et al, 2006; Ganasen et al, 2010; Gupta
et al, 2013; Hofmann et al, 2006a, 2006b; Myers and
Carlezon, 2012; Walker et al, 2002; Watson et al, 1990). In
addition, D-cycloserine effects on safety learning appear to
occur by augmenting the IL–amygdala circuitry (Chang and
Maren, 2011; Gupta et al, 2013; Ledgerwood et al, 2003;
Walker et al, 2002). In the current study, we investigated the
ability of social familiarity to selectively reduce anxiety-like
responses, determined the role of the PFC in this process,




Adult male Wistar rats (Harlan Laboratories, Indianapolis,
IN) between 300 and 350 g were used for all behavioral
experiments. Upon arrival at the facility, rats were
individually housed in a temperature-controlled room
(22 1C) and kept on a 12-h light–dark cycle (lights on at
0700 hours) with free access to food and water for at least 1
week before behavioral testing (Truitt et al, 2007). Rats were
handled daily for a minimum of 3 days before any behavior
testing. Cages were changed weekly. All cage changes
occurred after behavior testing and a minimum of 20 h
before the next day’s behavior testing. All experiments were
conducted in accordance to the NIH Guidelines for the Care
and Use of Laboratory Animals (NIH Publication no. 80-23,
revised in 1996) and according to the guidelines of the
Indiana University Purdue University at Indianapolis
Institutional Animal Care and Use Committee.
Bright Light Challenge
Anxiety-like behavior during SI testing was induced using a
bright light challenge (File and Hyde, 1978). The bright light
challenge consisted of an abrupt transition from dim red
light (40-watt red light, 1 lux) to bright white fluorescent
lighting (488 lux at the approximate eye level of the rats 8.5
feet from the light source) during the 5-min SI testing
session.
Behavioral Testing
Habituation and staging. Before behavioral testing or
habituation to the SI testing arena, rats were moved in their
home cages from the animal housing facility to a staging
room in the behavioral testing suite. The staging room was
constantly maintained under dim red light conditions and is
located adjacent to the room with the SI testing arena. Rats
habituated to the dim lighting in the staging room for a
minimum of 30min. Twenty-four hours before the first SI
test, rats were habituated to the SI apparatus by placing the
rat into the chamber alone for 5min under dim red lighting
conditions.
SI Test. The SI testing arena consists of a plexiglas open
top box with dimensions 91.44 cm length 91.44 cm
width 30.48 cm height. Just before SI testing, the experi-
mental rat and the partner rat were both carried into the
testing room within their home cages. Only one test was
performed within the testing room at a time and the
behavior box was thoroughly wiped down with a disin-
fectant cleaner between testing sessions. The protocol used
for the SI test has been described previously (Sanders and
Shekhar, 1995b; Shekhar and Katner, 1995). In brief, SI
testing consists of placing the experimental rat into the SI
box simultaneously with an age-, weight-, and sex-matched
conspecific partner for a 5-min test session. Each session is
video recorded from above and subsequently scored using
ODlog for Mac OS X version 2.6.1 by Macropod Software by
a treatment blind observer. SI time is measured as the
amount of time, in seconds, that the experimental rat
spends engaging in non-aggressive physical investigation of
the partner rat; defined by the experimental rat sniffing the
partner rat (none of the experimental rats displayed
aggressive behavior in these studies). Partner initiated
contact or investigation was independent of SI time, thus SI
times are independent of the partner’s behavior (none of the
partner rats used in these studies displayed avoidant or
aggressive behavior). Partner rats were used for a maximum
of two sessions in a single day and these sessions were
separated by at least 30min. This SI procedure has been
used for nearly two decades and has been validated as an
anxiety measure (Rainnie et al, 2004; Sajdyk and Gehlert,
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2000; Sanders and Shekhar, 1995a; Shekhar, 1994, 1996,
2002; Shekhar and Katner, 1995; Truitt et al, 2007). All SI
testing occurred between 0900 and 1300 hours (during the
rat’s light period).
SI-hab testing paradigm. The SI-hab test, described
previously (Truitt et al, 2007), consists of daily repeated
SI test sessions for a minimum of 5 consecutive days.
Variables that were manipulated during SI-hab testing
include lighting condition (bright light challenge or dim
light control), familiarity of partner rat (novel or familiar
partner (FP) rat for each day of SI-hab testing) and
pharmacological interventions.
Surgical Techniques
Rats were anesthetized by placing them in a Plexiglas box
connected to an IsoFlurane system (MGX Research
Machine, Vetamac, Rossville, IN). The animals were then
placed on a stereotaxic instrument (Kopf Instruments,
Tujunga, CA) with the incisor bar set at -4.5mm and kept
under a constant flow of isoflurane through a Plexiglas nose
cone. Rats were implanted bilaterally with 26-gauge
microinjection guide cannula (Plastics One, Roanoke, VA)
directed toward the IL PFC (AP þ 3.2mm, ML ±0.7, DV
 5mm) according to Paxinos and Watson (2005) atlas of
rat brain. All rats were given a minimum of 4 days recovery
before any behavioral testing. During recovery, rats were
gently handled each day for a minimum of 2min.
Histology
Rats with guide cannula were killed following the conclusion
of experiments, and brains were removed, flash frozen, and
stored at  80 1C until processed. Frozen brains were sliced
coronally at 30mm and every third section (separated by
90mm) was placed on a microscope slide. The sections were
counterstained on the slides with cresyl violet. The location of
bilateral injection sites was determined by damage left by
cannula and injectors from these 30-mm coronal Nissl-stained
sections through the frontal cortex at  5 magnification, and
confirmation at  40 (when needed), using rat brain atlas for
guidance (Paxinos and Watson, 2005). In all cases both
injection sites were located within the area designated IL
cortex within the PFC (Paxinos and Watson, 2005).
Statistics
All data were analyzed using Prism 6.0 Software (La Jolla,
CA) and all data are presented as mean±SEM. The
dependent variable for SI testing was duration of SI
(seconds). Comparisons of these data between two groups
with only one time point were made using Student’s t-test.
Comparisons from a single treatment group over multiple
days were made using a repeated measures one-way
ANOVA, whereas comparisons between two groups over
multiple days were made using a repeated measures two-
way ANOVA. In the presence of significant main effects of
day or day-by-treatment interaction, post hoc pairwise
comparisons were conducted. Dunnett’s test was used for
pairwise comparisons with the control day (first day of SI-
hab testing) within a treatment group; Tukey’s HSD test was
used for pairwise comparisons of a challenge day with other
days within treatment groups (or across days regardless of
group when main effect of day was observed in the absence
of an interaction); comparisons between treatment groups
for a given day were made using Bonferroni’s test or
Fisher’s LSD (where noted). The confidence level for
significance in all tests was set at po0.05.
Specific Experimental Protocols
Experiment 1. Rats were first given a baseline SI test in
dim red light with a novel partner (NP) rat. Forty-eight hours
later, the SI-hab testing paradigm was initiated. Rats were
divided into two groups based on lighting conditions during
SI-hab testing: dim light (n¼ 8) and bright light challenge
(n¼ 7). On the first SI-hab day, rats were paired with a NP
for the SI test. On SI-hab days 2–5, rats were then re-exposed
to the same partner (familiar) used in SI-hab day 1.
Experiment 2. The SI-hab paradigm was performed for 6
consecutive days. Rats were divided into two groups based on
partner condition. Rats in the novel partner group (n¼ 8)
were paired with a novel (unfamiliar) partner rat each SI-hab
day. Rats in the FP group (n¼ 8) were paired with the same
partner rat in each SI test. All SI testing sessions were
performed under the bright light challenge conditions.
Experiment 3. The SI-hab paradigm was performed in
bright light challenge conditions with the same partner
(familiar) for SI-hab days 1–5. On SI-hab day 6, the SI
testing was done with a NP rat in bright light challenge
conditions. The rats were then tested on day 13 with their
original FP under bright light challenge conditions, but this
time in a novel environment (different SI box in same
testing room).
Experiment 4. SI-hab paradigm was performed for 6
consecutive days. Days 1–5 were under dim light conditions
and with the same partner rat. On day 6, rats were divided
into two groups based on partner condition. Here, rats were
paired with either a NP (n¼ 5) or the same partner they had
been paired with for the first 5 days. The SI session on day 6
was performed under bright light challenge conditions.
Experiment 5. All SI tests were performed under bright
light challenge conditions. SI-hab testing was performed for
8 consecutive days with the same partner rat. On SI-hab
days 1–5 and again on day 8, rats were given a sham
intracranial (i.c.) injection 10min before SI testing (con-
sisting of a mock i.c. injection). Ten minutes before SI
testing on days 6 and 7, rats were given bilateral i.c.
injections into the IL of the mPFC of either 90 pmol
muscimol (Musc; Sigma-Aldrich, St Louis, MO) dissolved in
0.9% saline or 0.9% saline vehicle (Veh) at an injection
volume of 100 ml. The experiment was done in a counter-
balanced, cross-over design; an injection of one treatment
(either Veh or Musc) on day 6 and the opposite treatment
on day 7. This dose of Musc is similar to what has been used
to suppress mPFC nuclei specifically in relation to social or
fear/anxiety studies (Sierra-Mercado et al, 2011; van
Kerkhof et al, 2013a). Infusions were done at a rate of
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100 ml/min and injectors were allowed to remain in for an
additional minute before removal. On days 11 and 12, rats
once again were given bilateral i.c. injections into the IL of
either 90 pmol Musc or Veh in another counterbalanced
cross-over design, 10min before SI testing with a NP rat
under bright light challenge conditions.
Experiment 6. To habituate rats to being injected, rats
were brought into the behavior staging room and were
subcutaneously (s.c.) injected with 0.9% saline (1.0ml/kg)
once per day for the 2 days before the SI-hab paradigm. The
SI-hab paradigm was performed using the following
protocol; rats were injected 30min before SI testing, each
SI session was under bright light challenge conditions and
with the same partner rat for SI-hab days 1–5. On SI-hab
day 6, rats were challenged with a NP under bright light
challenge conditions and 30min following injection. All rats
were injected with saline (1.0ml/kg s.c.) on SI-hab day 1, the
first exposure to the partner rat. Rats were divided into two
groups based on the type of injection they received on SI-
hab days 2–6. On these days, rats were either injected with
saline (Veh group, n¼ 5) or D-cycloserine (10mg/kg in a
volume of 1.0ml/kg; DCS group, n¼ 5). The dose of
D-cycloserine was chosen because it was in the low-dose
range that was still effective at enhancing safety learning
(Ledgerwood et al, 2003; Walker et al, 2002).
RESULTS
Anxiety-Like Behavior is Reduced with Repeated
Exposures to a Familiar Conspecific
To determine whether the bright light challenge reduced SI
times, rats were divided into two groups based on lighting
conditions during SI testing, dim red lights (control, n¼ 11)
or bright light challenge, transitioning from dim light to
bright light immediately after being placed in the SI
chamber (bright light challenge, n¼ 11). Bright light
challenge rats had significantly reduced SI time compared
with control rats (SI time (mean±SEM) control¼ 21.45±
1.10 and challenge¼ 12.84±1.08; two-tailed unpaired t-test
t20¼ 5.57, po0.0001, data not shown). In experiment 1, the
effects of the bright light challenge were investigated in the
SI-hab paradigm. The basic experimental protocol for
experiment 1 is illustrated in the top of Figure 1a. In brief,
rats received a baseline SI testing session under dim light
and NP conditions (baseline). After 48 h, the SI-hab
protocol began and continued for 5 consecutive days
(SI-hab days 1–5). On the first SI-hab day, rats were paired
with a novel SI partner and then re-exposed to that same
partner (familiar) for the remainder of the experiment
(SI-hab days 2–5). Rats were divided into two groups based
on lighting conditions during SI-hab testing: dim light (n¼ 8)
and bright light challenge (n¼ 7). This paradigm produced a
main effect of day and day lighting condition interaction on
SI times (two-way repeated measures ANOVA, day
F5,65¼ 7.56, po0.0001; day lighting condition F5,65¼ 3.95,
p¼ 0.0034, Figure 1a). The bright light challenge significantly
reduced SI times in the bright light group on the first 2 days
of SI-hab testing compared with baseline (Tukey’s p¼ 0.0043
and p¼ 0.0088, respectively) and control rats (Bonferroni’s
p¼ 0.013 and p¼ 0.047, respectively). In the bright light
group, rats were repeatedly exposed to the same partner. SI
times significantly increased on the fourth and fifth exposure
to the same, familiar, partner rat compared with the SI times
of the first exposure to the partner, SI-hab day 1 (Dunnett’s
p¼ 0.0028 and po0.0001, respectively). This increase in SI
time observed over the SI-hab paradigm was not observed in
Figure 1 Anxiety-like behavior is reduced with repeated exposures to a familiar conspecific. (a) The effects of social familiarity on anxiety-like responses
to bright light challenge was investigated using the procedure illustrated in (a, top). Presented here are the mean±SEM of social interaction (SI) time in rats
continually tested under dim light conditions (dim light, n¼ 8) and rats tested under bright light challenge conditions (bright light, n¼ 7) during social
interaction–habituation test (SI-hab) days. Exposure to bright light challenge significantly reduced SI times in the bright light group compared with baseline
and dim light group. Repeated exposure to the same partner rat (social interacton-habituation, days 1–5) increased SI times compared with SI-hab day 1 on
the fourth and fifth exposure selectively in bright light rats, but not dim light rats. (b) Presence of a familiar partner (FP), but not a novel partner (NP),
selectively increases SI time during bright light challenge. Presented in b (top) is the procedural schematic used for this experiment. Presented in b (bottom)
are mean±SEM SI times for six sessions of SI-hab testing with a NP rat (NP, n¼ 8) or the same partner rat (FP, n¼ 8) in each session. Repeated SI testing
selectively increased SI times in the FP group but not the NP group. *Dunnett’s po0.05 different from D1; wTukey’s po0.05 different from dim light
condition within group (within group (a) and regardless of treatment group (b)); zBonferroni po0.05 different between treatment groups. Fam, familiar
partner; Nov, novel partner.
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the rats tested under dim light conditions (dim light group).
Thus, the increase in SI time that is acquired with multiple
exposures to a FP and bright light conditions can be
interpreted as a reduction in anxiety-like behavior.
Experiment 2 was designed to investigate the role of social
familiarity in the reduction in anxiety-like behavior obser-
ved in experiment 1. Here, rats were divided into two
groups, familiar partner (n¼ 8) or novel partner (n¼ 8).
Rats were exposed to the SI-hab protocol as described for
experiment 1 with the following exceptions: all SI sessions
were performed under bright light challenge conditions,
and rats in the novel partner group were tested with a NP
during each SI session, whereas rats in the FP group were
tested with the same partner during each of the six SI-hab
sessions (days 1–6, Figure 1b top). Here, main effects of day,
partner condition, and a day partner condition interac-
tion were observed (two-way repeated measures ANOVA,
day F5,70¼ 7.53, po0.0001; partner condition F1,14¼ 7.13,
p¼ 0.018; day partner condition F5,70¼ 3.72, p¼ 0.0048
Figure 1b graph). SI times increased over the SI-hab days in
the FP group but not in the NP group, with SI times in the
fourth through sixth sessions being significantly increased
compared with SI time of the first exposure to the partner
(Dunnett’s pp0.0003) and with SI times of the NP group
(Bonferroni’s pp0.038). Collectively, the results from
experiments 1 and 2 suggest that social familiarity has a
role in the anxiolytic-like response acquired over multiple
exposures to the bright light challenge.
The Role of Contextual Cues During Acquisition and
Expression of Anxiolytic-Like Responses to Social
Familiarity
Experiment 3 was designed to determine the role of social and
environmental context in the expression of anxiolytic-like
behaviors observed following repeated pairing of a FP and
bright light challenge. Rats were exposed to the SI-hab
paradigm with the same partner rat under bright light
challenge conditions on SI-hab days 1–6. As observed in
previous experiments, repeated SI testing with the same
partner under bright light challenge conditions leads to
increases in SI times (one-way repeated measures ANOVA
F5,30¼ 4.88, p¼ 0.015). SI times on days 5 and 6 were
significantly increased compared with the first exposure to
the partner (Dunnett’s pp0.014; Figure 2a). Rats were
exposed to a NP challenge on SI-hab day 7. Exposure to the
NP, under bright light challenge conditions, resulted in SI
times similar to day 1 and significantly reduced from day 6
(Tukey’s p¼ 0.043), suggesting that the presence of the FP is
required for the expression of the anxiolytic-like behavior.
Rats were then exposed to a novel environment challenge,
where rats were once again paired with the FP (used on days
1–6) under bright light challenge conditions but tested in a
different SI apparatus (black colored walls compared with
the light blue colored walls of the SI apparatus used for all
previous SI sessions). SI times in the novel environment
were once again significantly greater than day 1 SI times
(Dunnett’s p¼ 0.025) and SI times during the NP challenge
(Tukey’s p¼ 0.0012).
Experiment 4 was designed to investigate whether rats
will acquire anxiolytic-like responses to social familiarity
when the repeated exposure to a FP is performed in the
absence of an anxiogenic context. Here, rats were paired
with the same partner rat (FP) for 5 consecutive SI-hab days
under dim light conditions (FP:dim). The sixth SI-hab day
was a challenge day where all SI testing was performed
under bright light challenge conditions, and rats were either
paired with a NP or with the same partner (FP) they had
been paired with in the previous five SI-hab sessions that
were all performed under dim light conditions. This
Figure 2 Effects of social, environmental and anxiogenic context on expression and acquisition of social familiarity-induced anxiolysis (SFiA). Presented in
(a) are mean±SEM social interaction (SI) times for rats tested under bright light challenge conditions with the same partner for six social interaction–
habituation test (SI-hab) sessions, a novel partner challenge (NP) on the seventh (see a top for procedural schematic; NP challenge shaded region). (b) The
effect of context during social familiarity trials on social familiarity-induced reductions in anxiety-like response was investigated using the procedure illustrated
in b (top). All rats were paired with the same partner (familiar partner, FP) for SI testing under dim light conditions (FP:dim) for five SI-hab sessions. On the
sixth SI-hab session, SI testing was done under bright light challenge conditions in rats paired with their FP (FP:dim-FP, n¼ 7) or rats paired with a NP
(FP:dim-NP, n¼ 7). Bright light challenge reduced SI times regardless of testing with familiar or NP (NP challenge, shaded region). *Dunnett’s po0.05
different from Day 1; wTukey’s po0.05 different from Day 5 FP session. Fam, familiar partner; NE, novel environment challenge day; Nov, novel partner; NP,
novel partner challenge day.
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produced two groups: rats trained with a FP in dim light
conditions and exposed to a NP on the challenge day
(FP:dim-NP, n¼ 7), and rats trained with a FP in dim light
conditions and exposed to the same partner on the
challenge day ((FP:dim-FP, n¼ 7), see procedural schematic
Figure 2b top). This procedure resulted in a significant main
effect of day/light condition (two-way repeated measures
ANOVA, day F5,55¼ 4.36, p¼ 0.0021), but neither partner
condition main effect nor the interaction reached signifi-
cance. SI times on day 6, the bright light challenge, were
significantly lower than SI times on days 1 or 5, regardless
of the presence of a familiar or NP rat (Tukey’s p¼ 0.0005
and p¼ 0.035, respectively; Figure 2b). These results suggest
that social familiarity-induced anxiolysis (SFiA) is not
acquired when social familiarity pairings are done in the
absence of the anxiogenic stimulus.
The role of the mPFC in Expression of SFiA
Experiment 5 was designed to investigate the role of the
mPFC in the expression of the SFiA. Here, rats (n¼ 11) were
implanted with bilateral guide cannulae such that injections
were into the IL of the mPFC (Figure 3a). These rats were
tested in the SI-hab paradigm under bright light challenge
conditions with the same partner rat for 8 consecutive days
(see top of Figure 3b procedural schematic). Before the SI
session on days 1–5 and 8, rats were given a sham injection
10min before SI testing. Ten min before the SI session on
days 6 and 7, rats received i.c. injections of either Musc
(90 pmol/100 nl) or saline Veh (100 nl) in a counter-
balanced, cross-over design, where six rats received Veh
injections on day 6 and Musc injections on day 7, and the
other five rats received Musc injections on day 6 and Veh on
day 7. Repeated exposure to the same partner rat led to
significant increases in SI time (repeated measures ANOVA
F10,90¼ 4.60, po0.0001, Figure 3b), with SI times signifi-
cantly increased compared with day 1 on days 4, 5, and 8,
and following the IL Veh injection days (Dunnett’s
pp0.037). Interestingly, Musc injections into the IL blocked
this increase in SI time from day 1 (Dunnett’s p¼ 0.77) and
significantly reduced SI times compared with Veh injections
into the IL (Tukey’s p¼ 0.042). The reduction in SI time
following Musc injections into the IL appears specific to
social familiarity-induced increases in SI; Musc injections
into the IL before SI testing with a NP under bright light
conditions had no effect on SI time compared with Veh
injections (Figure 3a, NP challenge, shaded area of graph).
SI times with NP following Veh or Musc injections were
significantly reduced compared with SI times following Veh
injections with a FP (Tukey’s pp0.026) and were similar to
day 1 SI times. Conversely, under dim light conditions and
pairing with a novel rat, Musc injections into the IL resulted
in a slight but significant increase in SI time compared with
Veh injections into the IL (mean±SEM SI time, Veh
21.45±0.79, Musc 25.93±0.65; paired two-tailed t-test
t10¼ 2.28, p¼ 0.046).
D-Cycloserine Injections before Social Familiarity
Pairings Increased the Rate that SFiA was Acquired
Experiment 6 was designed to determine whether the
acquisition of SFiA could be enhanced by pairing social
familiarity exposure with systemic injections of the
cognitive enhancer D-cycloserine. Here, we a priori defined
SFiA acquisition as a significant increase in SI time
compared with the first exposure to the partner (SI-hab
Figure 3 Inhibiting the mPFC selectively blocks expression of social familiarity-induced anxiolysis (SFiA). Presented in (a) is a schematic representation of
the injection sites (modified from (Paxinos and Watson, 2005)). Pairs of black circles represent the bilateral injection site of each rat. Injections sites were
tightly located in the IL fromþ 4.0 to þ 3.5mm bregma. aca, anterior commissure, anterior part; CCfmi, corpus callosum forceps minor; IL, infralimibic cortex;
PrL, prelimibic cortex. Presented in (b) are mean±SEM social interaction (SI) times for rats (n¼ 11) tested under bright light challenge conditions with the
same partner for eight social interaction–habituation test (SI-hab) sessions (see top of figure for procedural schematic). Muscimol (Musc—solid black bar),
but not vehicle (Veh—solid gray bar), injected into the IL 10min before SI testing blocked the social familiarity-induced increase in SI times observed over
the first five SI-hab sessions. The blockade of SFiA by Musc into the mPFC was temporary, as SI times were significantly increased compared with SI times
following the Musc injections on the next SI-hab session. In the novel partner (NP) challenge (shaded region), SI times following both Veh (open gray bar)
and Musc (open black bar) injections into the mPFC were reduced equally compared with those of Veh injections with familiar partner (FP, solid gray bar).
*Dunnett’s po0.05 different from D1; wTukey’s po0.05 different Veh injection with FP.
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day 1), and the rate of acquisition as the number of SI-hab
pairings required to achieve this significant increase in SI
time. To habituate rats to being injected, rats were brought
into the behavior staging room and were subcutaneously
(s.c.) injected with 0.9% saline (1.0ml/kg) once per day for
two days before the SI-hab paradigm. The SI-hab paradigm
was performed using the following protocol (Figure 4 top);
rats were injected 30min before SI testing, each SI session
was under bright light challenge conditions and with the
same partner rat for SI-hab days 1–5. On SI-hab day 6,
30min following injection, rats were challenged with a NP
under bright light challenge conditions. All rats were
injected with saline (1.0ml/kg s.c.) on SI-hab day 1, the
first exposure to the partner rat. Rats were divided into two
groups based on the type of injection they received on SI-
hab days 2–6. On these days, rats were either injected with
saline (Veh group, n¼ 5) or D-cycloserine (10mg/kg in a
volume of 1.0ml/kg; DCS group, n¼ 5). As previously
observed, social familiarity produced an increase in SI time
across days (two-way repeated measures ANOVA main day
effect F5, 40¼ 13.16, po0.0001 Figure 4). However, D-cyclo-
serine treatment affected the rate at which this increase in SI
time occurred over the first 3 days of repeated exposure to
the partner rat (day treatment interaction F2,16¼ 7.84,
p¼ 0.0042). Rats treated with D-cycloserine had signifi-
cantly increased SI times on the third SI session (SI-hab day
3) and lasting through session 5, compared with the first
day of exposure to the partner (Dunnett’s pp0.031),
whereas SI times of Veh-treated rats were not significantly
increased, compared with day 1, until the fifth exposure to
the partner rat (Dunnett’s p¼ 0.002). In addition, the SI
times of the DSC group were significantly increased
compared with Veh group SI times on SI-hab days 3 and
4 (Fisher’s LSD pp0.027). As D-cycloserine has previously
been reported to have prosocial effects in mice (Jacome
et al, 2011), both Veh- and D-cycloserine-injected rats were
exposed to a NP challenge for the sixth SI session. If
D-cycloserine injections were producing prosocial effects,
then it would be expected that the SI times during the NP
challenge would remain elevated and increased compared
with the SI times of the first SI-hab session (day 1) and with
SI times of the Veh group. SI pairing with a NP resulted in a
significant reduction in SI time compared with SI times of
the rat’s previous SI session (day 5) for both D-cycloserine-
and Veh-treated rats (Tukey’s p¼ 0.018 and p¼ 0.005,
respectively). Furthermore, the SI times for each group were
not significantly different compared with day 1 SI times
(Dunnett’s (Veh) p¼ 0.999 and (DCS) p¼ 0.073) or between
groups (day 6, Fisher’s LSD p¼ 0.072). However, comparing
D-cycloserine effects on SI time only during the NP
conditions (day 1 and day 6) resulted in a main effect of
day (two-way repeated measures ANOVA main day effect
F1, 8¼ 5.89, p¼ 0.041) and a day treatment interaction
(F1, 8¼ 6.40 p¼ 0.035). In this, less stringent analysis (as a
result of reducing the multiple comparisons) SI times of
DCS rats are significantly greater on day 6 compared with
day 1 (within) and also compared with SI time of Veh rats
on day 6 (Fisher’s LSD p¼ 0.008 and p¼ 0.024, respec-
tively). Thus, interpretations of these data are limited.
DISCUSSION
Social Familiarity-Induced Anxiolysis
The concept that overcoming fear and anxiety is easier in
the presence of a familiar person (eg, friend or therapist) is
commonly accepted and a critical component of cognitive
behavioral therapy (Baldwin et al, 2007; Martin et al, 2000;
McHugh et al, 2013; Roshanaei-Moghaddam et al, 2011).
Yet, few studies have systematically investigated this effect
and little is known of the neural mechanisms that regulate
this SFiA. The current study is one of the first to
systematically investigate SFiA in an animal model. Here,
we present an animal model in which social familiarity
selectively reduces anxiety-like responses to a naturally
anxiogenic stimulus, bright light challenge, but does not
alter baseline anxiety behaviors as measured by the SI test
(Crawley and Goodwin, 1980; de Jongh et al, 2002; DeFries
et al, 1966; Walker and Davis, 1997). Previous studies using
the SI test reported that bright light only consistently
reduced SI times when paired with a novel environment
(File and Hyde, 1978). To enhance the anxiogenic effect of
bright light in the SI test, a bright light challenge, consisting
of quickly transitioning from dim light to bright light after
the rats are in the SI chamber, was used in the current
study. Here, the bright light challenge resulted in consistent
and reliable reductions in SI times, and the rats did not
habituate to this anxiogenic stimulus over 6 days. The SI
times observed in these experiments are within the range of
SI scores from similar experiments using the same SI
scoring methodology (Sajdyk and Gehlert, 2000; Shekhar
et al, 2002; Truitt et al, 2007).
Figure 4 D-cylcoserine injections enhanced the rate at which SFiA is
acquired. Presented in the top of the figure is a schematic representation of
the protocol used for this experiment. Presented here are mean±SEM
social interaction (SI) times for rats injected with vehicle (Veh, n¼ 5) or
D-cycloserine (DCS, n¼ 5). All SI testing was performed under bright light
challenge conditions and all rats were initially injected with vehicle (0.9%
saline) 30min before SI testing on day 1. On subsequent days, the
D-cycloserine (DCS 10mg/kg) replaced vehicle injection in the DCS group.
Both groups of rats expressed social familiarity-induced anxiolysis (SFiA).
However, the DCS rats expressed it more rapidly than Veh rats (DSC rats
day 3, Veh rats day 5). Novel partner (NP) challenge (day 6 shaded region)
reduced SI times compared with day 5 in both DCS and Veh rats.
*Dunnett’s po0.05 different from Day 1; wTukey’s po0.05 different from Day 5
within group; zFisher’s LSD pp0.027 different between treatment groups.
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The reduction in SI times induced by the bright light
challenge was overridden by the fourth or fifth pairing with
a familiar rat. These increases in SI time with repeated
exposures to a familiar rat appear to be an anxiolytic-like
response rather than a general increase in prosocial
behavior. Social familiarity did not affect SI times in the
absence of anxiogenic stimuli and anxiety-like responses to
the bright light challenge returned when the FP rat was
replaced with a NP. These results are similar to past findings
in which social familiarity had no effect on control rats, but
reduced anxiety-like behaviors in rats made persistently
anxious by a pharmacological manipulation directly to
the BLA (Truitt et al, 2007), a procedure that leads to
lasting increases in anxiety-like behaviors and increased
excitability of the BLA (Rainnie et al, 2004; Truitt et al,
2007). In addition, acquisition of this anxiolytic-like
behavior appears to be specifically linked to the FP,
as rats failed to acquire an anxiolytic-like response to the
bright light challenge when a NP was used for each of the
repeated SI sessions. Furthermore, the anxiolytic-like
response in the presence of a socially FP remained even
when the SI test was done in a different testing environ-
ment. Collectively, these results support the idea that
the acquisition of anxiolytic-like behavior in this paradigm
is dependent on social familiarity and unlikely to be a
result of habituation to the testing environment or the
bright light stimulus. In addition to social familiarity,
acquisition of the anxiolytic-like behavior also appears to be
linked to anxiety-like conditions during repeated pairing
with the partner rat. Social familiarity had no effect on
anxiety-like behavior when the repeated pairings with the
same partner rat was done under dim light (low anxiety-
like) conditions.
Social Familiarity and Safety Cues
SFiA appears to be acquired over multiple pairings of a FP
rat and the anxiogenic stimulus. After SFiA is acquired, the
presence of the familiar rat remains pivotal for the
expression of the anxiolysis, as anxiety-like behavior
returns when the familiar rat is replaced with a novel rat
(current data and (Truitt et al, 2007)). Collectively, these
data could be interpreted, as SFiA is a conditioned response
and the familiar rat acts as a cue. However, typically when
cues are repeatedly paired with unconditioned aversive
stimuli, they are avoided or the cue itself starts to induce
fear or anxiety responses (Maren and Quirk, 2004; Thielen
and Shekhar, 2002). As the presence of the FP reduces
anxiety-like behavior, the partner rat may be acting as a
safety cue, in which case SFiA could be considered a form of
safety learning (Christianson et al, 2012). In support of this
concept, it was observed that the context during the
repeated exposures to a conspecific determined the extent
to which anxiolysis would result upon subsequent expo-
sures. When the social familiarity training occurred under
non-threatening conditions, social familiarity failed to
induce anxiolysis in response to the bright light challenge.
At this point, it is unclear whether the presence of the
anxiogenic stimulus during the social familiarity training
session enhances the social memory of the partner rat or is
required to activate an anxiolytic pathway that is specific to
the type of anxiogenic cue.
The mPFC and SFiA
The rodent and human mPFC are implicated in both social
processing and cortical regulation of anxiety/fear, making it
a compelling target as the cortical site for regulation of SFiA
(Adolphs, 2010; Fossati, 2012; Hartley and Phelps, 2010;
Meyer-Lindenberg and Tost, 2012; Milad and Quirk, 2002;
van Kerkhof et al, 2013a, 2013b). In the current study,
expression of SFiA appears to be dependent on an active
mPFC. Temporary inhibition of the mPFC, by local
injections of Musc into the IL (of the mPFC), blocked the
social familiarity-induced reduction in anxiety-like re-
sponses to the bright light challenge. This effect of
inhibiting the mPFC appeared selective to SFiA, as it did
not alter anxiety-like responses to the bright light challenge
in the presence of a novel rat. In this study, all of the
injections were localized to the IL; however, it is possible
that the effects of the Musc injections were as a result of
diffusion beyond the IL, and thus our interpretation of these
results are limited to the mPFC. Although inhibiting the
mPFC appears to selectively suppress SFiA, it is unclear if
this suppression is a result of disrupting top-down
regulation of anxiety or a result of disrupting social
cognition, such as the ability to recall the partner rat as
familiar. In terms of social cognition, the mPFC is cited as a
locus for integration of social stimuli and emotional
responses (Adolphs, 2009; Amodio and Frith, 2006).
Thickness of the (v)mPFC is associated with social
functioning and ability to correctly interpret emotion from
social cues (Holmes et al, 2012). In a recent animal study,
the importance of the mPFC in developmentally relevant
social behavior, social play, was demonstrated through
inactivation of the mPFC (van Kerkhof et al, 2013a). The
authors also reported that inactivation of the mPFC (in a
non-threatening environment) increased social investiga-
tion, which is a similar measure to the increase in SI time
reported under similar conditions in the current study.
Thus under basal conditions, the mPFC appears to suppress
SIs/investigations; however, under threatening conditions,
the mPFC appears to be involved in the expression of
anxiolytic social learning. This latter point is likely related
to the mPFC’s role in top-down regulation of anxiety.
Suppression of anxiety or fear responses by different forms
of cognitive behavioral therapies and extinction involves
activation of the mPFC (Eisenberger et al, 2011; Hartley and
Phelps, 2010; Kim et al, 2011a; Milad and Quirk, 2002;
Phelps et al, 2004; Schiller et al, 2008; Sotres-Bayon and
Quirk, 2010). The mPFC is a site where extinction of
conditioned fear is consolidated in rodents (Laurent and
Westbrook, 2009; Peters et al, 2010; Santini et al, 2012).
Similarly, the mPFC responds greater to stimuli-signaling
safety compared with fear predictive stimuli, in human
imaging studies of fear-conditioning extinction (Kalisch
et al, 2006; Milad et al, 2007; Phelps et al, 2004) and
specifically safety cues in a fear-conditioning reversal
paradigm (Schiller et al, 2008). In addition, activation of
the mPFC during a threat was selectively increased while
viewing images of a familiar person compared with an
unfamiliar person, and the strength of the relationship with
the familiar person correlated positively with threat-
induced activation of the mPFC, suggesting that mPFC
activation was related to the value of the person as a safety
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signal (Eisenberger et al, 2011). The value of familiar rats as
a safety signal in the current study was also dependent on
the mPFC.
Enhancement of SFiA with D-Cycloserine
The current data support the idea that in the process of
SFiA, the FP rat becomes a safety signal. This is based on the
observations that acquisition of SFiA appears to require
repeated pairings of the socially FP rat with the anxiogenic
stimulus, the presence of the familiar conspecific is
necessary for the expression of SFiA, and SFiA is dependent
on an active mPFC that is a pivotal site for safety learning.
Safety learning in humans and rodents can be enhanced by
pairing the safety learning with D-cycloserine (Davis et al,
2006; Gupta et al, 2013; Hofmann et al, 2006b). D-cyclo-
serine augmentation of cognitive behavioral therapy for
social anxiety, in particular, was associated with a faster rate
of improvement (Hofmann et al, 2013). Similarly, in the
current study, pretreatment with D-cycloserine before
pairings with the familiar conspecific reduced the number
of SI training sessions required to reduce the anxiety-like
response to the anxiogenic challenge. A potential caveat of
this observation is that D-cycloserine treatment increased
prosocial behavior in other rodent models (Myers and
Carlezon, 2012) that could confound the current inter-
pretations of the SI behavior. To determine the extent to
which prosocial effects of D-cycloserine were contributing
to the enhanced SFiA, rats were pretreated with D-cyclo-
serine and tested with a NP after SFiA was established. Here,
in the presence of a NP, SI times compared with the last
SFiA session were significantly reduced compared with the
last SFiA session and no longer significantly higher than day
1, regardless of receiving D-cycloserine or Veh injection.
From these data, it can be interpreted that the enhanced
acquisition of SFiA observed with D-cycloserine was at least
in part due to enhanced social learning rather than
enhanced prosocial behavior. Alternatively, the D-cycloser-
ine-treated rats displayed a strong trend toward increased
SI times during the NP challenge, which reached signifi-
cance when not controlling for multiple comparisons,
implying the possibility of a prosocial effect induced by
D-cycloserine that appears to be additive with the SFiA
response. Further studies are needed to fully resolve the
mechanism by which D-cycloserine enhances the acquisi-
tion of SFiA.
Contrary to the concept that in SFiA, the FP becomes a
safety signal is the idea of an innate social buffering
response. Social buffering studies have demonstrated that
the presence of a conspecific can reduce fear and stress
responses in conditioned fear paradigms without any
training (Davitz and Mason, 1955; Kiyokawa et al, 2009,
2012; Latane, 1969; Terranova et al, 1999), suggesting that a
conspecific may serve as an external inhibitor of fear or
anxiety rather than a safety signal (Christianson et al, 2012).
Social buffering effects were not directly investigated in the
current study of SFiA. However, SFiA differs from social
buffering in several key areas. First, SFiA overrides an
unconditioned anxiogenic stimulus, whereas most social
buffering experiments use a conditioned fear as the
stimulus. Next, SFiA was acquired only following ‘training’,
requiring between 4–5 pairings of the familiar conspecific
with the anxiogenic stimuli, suggesting that the social
familiarity is acting more like a safety signal than external
inhibitor. Finally, expression of SFiA appears to require an
active mPFC, whereas social buffering effects in response to
the presence of a conspecific at the time of testing appear to
be independent of mPFC activation (Kiyokawa et al, 2007,
2009).
Concluding Remarks
The current study is one of the first to present a preclinical
behavioral model by which the anxiolytic effects of social
familiarity can be investigated. In this model, reductions in
anxiety-like responses are selective to social familiarity and
appear to require the presence of the FP. SFiA appears to be
a learned response, where the context in which social
familiarity is established determines the extent to which
familiarity will induce anxiolysis. In addition, the mPFC is
critical to expression of SFiA, similar to findings in other
safety-learning paradigms. Finally, the cognitive enhancer
D-cycloserine enhanced the acquisition of SFiA.
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